We entered FBXO7, RAD23A, and MKRN1 into the camp database and eventually identified 11 drugs that could be used to treat coronary artery disease, including doxorubicin, gabapentin, suxibuzone, prasterone, kawain, 5255229, decline, nalbuphine, MK-801, trimethoprim, and GW-8510 (Table 1). Here, FBXO7 is linked to coronary artery disorder.